Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission

被引：0
|
作者：
Versluis, Jurjen [1 ]
Cornelissen, Jan J. [1 ]
机构：
[1] Erasmus MC, Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
HEMASPHERE | 2018年 / 2卷
关键词：
D O I：
10.1097/HS9.0000000000000119
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 164
页数：3
相关论文
共 50 条
  • [1] GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION
    Versluis, J.
    Kalin, B.
    Zeijlemaker, W.
    Passweg, J.
    Graux, C.
    Manz, M.
    Vekemans, M-C
    Biemond, B.
    Legdeur, M-C
    Kooy, M. van Marwijk
    Janssen, J.
    Pabst, T.
    Lowenberg, B.
    Jongen-Lavrencic, M.
    Schuurhuis, G. J.
    Ossenkoppele, G.
    Cornelissen, J.
    HAEMATOLOGICA, 2017, 102 : 7 - 7
  • [2] Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
    Walter, Roland B.
    Buckley, Sarah A.
    Pagel, John M.
    Wood, Brent L.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Fang, Min
    Gyurkocza, Boglarka
    Delaney, Colleen
    Radich, Jerald P.
    Estey, Elihu H.
    Appelbaum, Frederick R.
    BLOOD, 2013, 122 (10) : 1813 - 1821
  • [3] Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
    Walter, Roland B.
    Gyurkocza, Boglarka
    Storer, Barry E.
    Pagel, John M.
    Buckley, Sarah A.
    Sorror, Mohamed L.
    Delaney, Colleen
    Wood, Brent L.
    Deeg, H. Joachim
    Storb, Rainer
    Appelbaum, Frederick R.
    Sandmaier, Brenda M.
    BLOOD, 2013, 122 (21)
  • [4] Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
    Walter, R. B.
    Gyurkocza, B.
    Storer, B. E.
    Godwin, C. D.
    Pagel, J. M.
    Buckley, S. A.
    Sorror, M. L.
    Wood, B. L.
    Storb, R.
    Appelbaum, F. R.
    Sandmaier, B. M.
    LEUKEMIA, 2015, 29 (01) : 137 - 144
  • [5] Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
    R B Walter
    B Gyurkocza
    B E Storer
    C D Godwin
    J M Pagel
    S A Buckley
    M L Sorror
    B L Wood
    R Storb
    F R Appelbaum
    B M Sandmaier
    Leukemia, 2015, 29 : 137 - 144
  • [6] Hematopoietic stem cell transplantation for patients with AML in first complete remission
    Cornelissen, Jan J.
    Blaise, Didier
    BLOOD, 2016, 127 (01) : 62 - 70
  • [7] Allogeneic stem cell transplantation in first complete remission
    Oran, Betul
    Weisdorf, Daniel J.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 395 - 400
  • [8] Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML- A strong case for allogeneic stem cell transplantation in first complete remission
    Stahl, Maximilian
    Tallman, Martin S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 806 - 808
  • [9] Impact of minimal residual disease in adult patients with acute myeloid leukaemia in complete remission undergoing allogeneic haematopoietic stem cell transplantation
    Grubovic, R. M.
    Schiller, G. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S382 - S383
  • [10] Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission
    Versluis, Jurjen
    Kalin, Burak
    Zeijlemaker, Wendelien
    Passweg, Jakob
    Graux, Carlos
    Manz, Markus G.
    Vekemans, Marie-Christiane
    Biemond, Bart J.
    Legdeur, Marie-Cecile J. C.
    Kooy, Marinus van Marwijk
    de Weerdt, Okke
    Wijermans, Pierre W.
    Hoogendoorn, Mels
    Bargetzi, Mario J.
    Kuball, Juergen
    Schouten, Harry C.
    van der Velden, Vincent H. J.
    Janssen, Jeroen J. W. M.
    Pabst, Thomas
    Lowenberg, Bob
    Jongen-Lavrencic, Mojca
    Schuurhuis, Gerrit Jan
    Ossenkoppele, Gert
    Cornelissen, Jan J.
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 13
12345